PascalFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Association médicamenteuse »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Association morbide < Association médicamenteuse < Astrocyte  Facettes :

List of bibliographic references indexed by Association médicamenteuse

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
003301 (2001) Richard Camicioli [États-Unis, Canada] ; Eric Lea [États-Unis] ; John G. Nutt [États-Unis] ; Gary Sexton [États-Unis] ; Barry S. Oken [États-Unis]Methylphenidate increases the motor effects of L-Dopa in Parkinson's disease: A pilot study
003332 (2001) ABDALLAH HADJ TAHAR [Canada] ; Anna Ekesbo [Suède] ; Laurent Gregoire [Canada] ; Evelyne Bangassoro [Canada] ; Kjell A. Svensson [États-Unis] ; Joakim Tedroff [Suède] ; Paul J. Bedard [Canada]Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeys
003345 (2001) Oksana Suchowersky [États-Unis, Canada] ; Peter Bailey ; E. Pourcher ; Lynne Bulger ; Giovanni FacciponteComparison of two dosages of tolcapone added to levodopa in nonfluctuating patients with PD
003551 (2000) D. J. Chong [Canada] ; O. Suchowersky [Canada] ; C. Szumlanski [États-Unis] ; R. M. Weinshilboum [États-Unis] ; R. Brant [Canada] ; N. R. C. Campbell [Canada]The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's Disease
003827 (1999) V. D. Doan [Canada] ; R. Grondin [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; L. Gregoire [Canada] ; P. J. Bedard [Canada]Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys
003C35 (1997) I. H. Richard [États-Unis] ; R. Kurlan [États-Unis] ; C. Tanner [États-Unis] ; S. Factor [États-Unis] ; J. Hubble [États-Unis] ; O. Suchowersky [Canada] ; C. Waters [États-Unis]Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease
003C61 (1997) D. J. Doudet [Canada] ; G. L. Y. Chan [Canada] ; J. E. Holden [États-Unis] ; K. S. Morrison [Canada] ; R. J. Wyatt [États-Unis] ; T. J. Ruth [Canada]Effects of catechol-O-methyltransferase inhibition on the rates of uptake and reversibility of 6-fluoro-L-dopa trapping in MPTP-induced Parkinsonism in monkeys
003F76 (1995) Céline Gagnon [Canada] ; Baltazar Gomez-Mancilla [Canada] ; Rudolf Markstein [Suisse] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of adding the D-1 agonist CY 208–243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors
004430 (1993) M. Guttman [Canada] ; G. Léger [Canada] ; A. Reches [Israël] ; A. Evans [Canada] ; H. Kuwabara [Canada] ; J. M. Cedarbaum [États-Unis] ; J. M. Gjedde [Canada]Administration of the new COMT inhibitor OR‐611 increases striatal uptake of fluorodopa
004649 (1992) B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. BedardEffect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of Parkinsonism
004826 (1991) B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. BedardEffect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism
004897 (1990) C. Rouillard [Canada] ; P. J. Bédard [Canada] ; T. Di Paolo [Canada]Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393
004985 (1990) N. R. C. Campbell ; D. Rankine ; A. E. Goodridge ; B. B. Hasinoff ; M. KaraSinemet-ferrous sulphate interaction in patients with Parkinson's disease
004D90 (1987) H. A. Robertson ; G. S. RobertsonHypothesis. Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action
004F03 (1986) E. Lau ; K. Waterman ; R. Glover ; M. Schulzer ; D. B. CalneEffect of antacid on levodopa therapy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Association médicamenteuse" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Association médicamenteuse" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Association médicamenteuse
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022